Comparison of different concentrations of mesotherapy with tranexamic acid in patients with the complaint of Darkness around the eyes

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240926063171N1

Enrollment

Registered

2024-11-21

Start date

2024-10-22

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Darkness around the eyes.

Interventions

Intervention 1: Intervention group:in Intervention group one, patients with dark circles around the eyes, the combination of the same AB means that the lower right eyelid A and the lower left eyelid B

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Not in the context of atopic dermatitis Has not been treated with PRP and mesotherapy in the last 6 months The form has been taken knowingly Darkness around the eyes has been confirmed by a dermatologist

Exclusion criteria

Exclusion criteria: pregnancy breastfeeding Receiving anticoagulant medication

Design outcomes

Primary

Measure	Time frame
Darkness and hyperpigmentation around the eyes. Timepoint: before the start of treatment, three weeks after the start of therapy and the third time 8 to 12 weeks after the start of treatment. Method of measurement: During three rounds, photos are taken using an 8 megapixel digital camera.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNasim mazloomi tootoonchi

Tehran University of Medical Sciences

ansarims@sina.tums.ac.ir+98 21 5563 4461

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026